These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 2575060
1. Omeprazole in the treatment of Zollinger-Ellison syndrome and histamine H2-antagonist refractory ulcers. Meijer JL, Jansen JB, Lamers CB. Digestion; 1989; 44 Suppl 1():31-9. PubMed ID: 2575060 [Abstract] [Full Text] [Related]
2. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Clissold SP, Campoli-Richards DM. Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658 [Abstract] [Full Text] [Related]
3. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists. Lambers CB, Lind T, Moberg S, Jansen JB, Olbe L. N Engl J Med; 1984 Mar 22; 310(12):758-61. PubMed ID: 6142418 [Abstract] [Full Text] [Related]
4. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Hirschowitz BI, Mohnen J, Shaw S. Aliment Pharmacol Ther; 1996 Aug 22; 10(4):497-506. PubMed ID: 8853753 [Abstract] [Full Text] [Related]
5. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study. Maton PN, Vinayek R, Frucht H, McArthur KA, Miller LS, Saeed ZA, Gardner JD, Jensen RT. Gastroenterology; 1989 Oct 22; 97(4):827-36. PubMed ID: 2777040 [Abstract] [Full Text] [Related]
6. Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Maton PN, Gardner JD, Jensen RT. Gastroenterol Clin North Am; 1989 Dec 22; 18(4):847-63. PubMed ID: 2575602 [Abstract] [Full Text] [Related]
7. Role of acid suppressants in patients with Zollinger-Ellison syndrome. Maton PN. Aliment Pharmacol Ther; 1991 Dec 22; 5 Suppl 1():25-35. PubMed ID: 1679671 [Abstract] [Full Text] [Related]
8. The clinical utility and safety of omeprazole. Walan A. Scand J Gastroenterol Suppl; 1989 Dec 22; 166():140-4; discussion 145. PubMed ID: 2574908 [Abstract] [Full Text] [Related]
9. Omeprazole: a comprehensive review. Massoomi F, Savage J, Destache CJ. Pharmacotherapy; 1993 Dec 22; 13(1):46-59. PubMed ID: 8437967 [Abstract] [Full Text] [Related]
10. [Therapeutic achlorhydria: for which diseases, when and for how long?]. Koop H, Arnold R. Dtsch Med Wochenschr; 1988 Mar 31; 113(13):516-8. PubMed ID: 2894969 [No Abstract] [Full Text] [Related]
11. [Omeprazole in the therapy of acid-induced diseases]. Simon B, Dammann HG, Müller P. Z Gastroenterol; 1987 Aug 31; 25 Suppl 3():146-51. PubMed ID: 2889299 [Abstract] [Full Text] [Related]
12. Present experiences with omeprazole in the Zollinger-Ellison syndrome. Lamers CB. Scand J Gastroenterol Suppl; 1986 Aug 31; 118():123-8. PubMed ID: 3460167 [Abstract] [Full Text] [Related]
13. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome. McArthur KE, Collen MJ, Maton PN, Cherner JA, Howard JM, Ciarleglio CA, Cornelius MJ, Jensen RT, Gardner JD. Gastroenterology; 1985 Apr 31; 88(4):939-44. PubMed ID: 3972233 [Abstract] [Full Text] [Related]